FDA Needs To Weigh Foreign Inspections More Heavily - SOCMA
This article was originally published in The Tan Sheet
Despite plans to increase overseas inspections for fiscal 2010, FDA's refusal to risk-rank domestic and foreign manufacturers together puts U.S. firms at a disadvantage, according to the Society of Chemical Manufacturers and Affiliates
You may also be interested in...
FDA will shoot to double its inspections of foreign facilities in fiscal 2010 to more than 2,000
FDA plans to hold a public workshop this spring to begin the task of combating profit-motivated adulteration of regulated products
Over-the-counter drugs made with imported ingredients are at greater risk of contamination than prescription products, experts told a House panel on Nov. 1